Clinical Trial Update: Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells [NA]

View source ↗

Summary

A terminated clinical trial investigated molecular mechanisms of inherited arrhythmias and valvulopathies using induced pluripotent stem cells.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inherited Arrhythmia Syndromes
• Valvular Heart Disease

Snippet

Sponsor: Nantes University Hospital | Conditions: Inherited Arrhythmias and Valvulopathies | NA | Status: TERMINATED